Discovery of an Ultrasound-Responsive Arylurea-Dihydrotetrazine Architecture for Ultrasound-Programmed Bioorthogonal Chemistry
Journal of the American Chemical Society · 2026
DOI: 10.1021/jacs.6c13439 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, 2026. Verfasst von Shuanglong Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines, Center of Drug Discovery, China Pharmaceutical University, Nanjing, Jiangsu211198, China. Hauptthemen laut MEDLINE: Urea, Ultrasonic Waves, Antineoplastic Agents, Tetrazoles. Die Arbeit nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, Lingang Laboratory.
Abstract (Originalsprache)
Ultrasound-responsive chemical scaffolds capable of operating under clinically relevant conditions remain rare, limiting the development of programmable ultrasound-controlled molecular systems. Here, we report the discovery of a stable yet ultrasound-responsive arylurea-dihydrotetrazine (ArU-DHTz) scaffold that undergoes efficient activation under 1 MHz therapeutic ultrasound without requiring exogenous sonosensitizers. Structure–responsiveness studies revealed that activation arises from a unique combination of a monosubstituted arylurea motif and an appropriately tuned DHTz core, while mechanistic investigations identified cavitation-derived hydroxyl radicals as the primary activating species. Ultrasound activation simultaneously triggers cargo release and tetrazine generation, representing, to our knowledge, the first example of ultrasound-triggered tetrazine formation. Leveraging tetrazine as a chemical relay, we developed a “Release–Relay–Click” strategy that converts a single ultrasound input into dual molecular outputs: therapeutic payload release and downstream click-to-release activation. Representative prodrug D6 showed ultrasound-dependent activation, translating into antitumor efficacy in vitro and in vivo, together with fluorescence self-reporting through tetrazine-mediated bioorthogonal chemistry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Natural Medicines, Center of Drug Discovery, China Pharmaceutical University, Nanjing, Jiangsu211198, China.
ORCID-Profile: Weiwei Guo, Yueqin Zheng
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
- Lingang Laboratory
Zitieren
APA
Chen, S., Chang, J., Cheng, M., Ban, C., Guo, W., & Zheng, Y. (2026). Discovery of an Ultrasound-Responsive Arylurea-Dihydrotetrazine Architecture for Ultrasound-Programmed Bioorthogonal Chemistry. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.6c13439
Vancouver
Chen S, Chang J, Cheng M, Ban C, Guo W, Zheng Y. Discovery of an Ultrasound-Responsive Arylurea-Dihydrotetrazine Architecture for Ultrasound-Programmed Bioorthogonal Chemistry. Journal of the American Chemical Society. 2026. doi:10.1021/jacs.6c13439
BibTeX
@article{Chen2026,
author = {Chen, Shuanglong and Chang, Jiaxin and Cheng, Mingxin and Ban, Chao and Guo, Weiwei and Zheng, Yueqin},
title = {Discovery of an Ultrasound-Responsive Arylurea-Dihydrotetrazine Architecture for Ultrasound-Programmed Bioorthogonal Chemistry},
journal = {Journal of the American Chemical Society},
year = {2026},
doi = {10.1021/jacs.6c13439}
}
EUVIMED